BUSINESS● LOW3d ago · Oct 23, 2026, 11:10 PM
Dr. Reddy’s outlines semaglutide relaunch in November 2026 and reiterates 6M-7M devices target
Seeking Alpha Tech · global
Dr. Reddy's has announced plans to relaunch semaglutide in November 2026 and reaffirmed its target of 6-7 million devices. This indicates a future business strategy and production goal for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS34m agoChina industrial profits post strongest growth in three months, rising 14.4%CNBCBUSINESS42m agoSouth Korea's chip boom fuels forecast-beating third-quarter growthJapan Today